Home › Studies › PRJNA1109584
PRJNA1109584 SRP506664

Healthy adults, inulin/psyllium crossover trial

Metagenomic sequencing of stool samples from healthy human volunteers from the EON study

15 stool samples from healthy adult volunteers in a crossover trial testing inulin given alone, with psyllium, or in divided doses, examining effects on breath hydrogen and gut microbiota. machine-written summary

15 samples · 15 runs · GB · Adult · 2025 · 4.15 Gbp / sample

Sources
✓Sequence archive 90○Abstract / description✓Full text 60○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive90 sample values (collection date, country, latitude, location locality, location region, longitude)
○ Abstract / descriptionread; no usable statement
✓ Full text60 sample values (health condition, health condition detail, location site, subject id) · PMC11934246
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Prebiotic / dietary fibre supplement design crossover · population healthy_control · 20g inulin vs psyllium vs divided-dose inulin vs maltodextrin placebo, crossover

“consumed 20 g inulin (I) powder” — abstract:39732438 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult15
Condition
healthy_control15
Country
GB15
Body site
primary15
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 1 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 1 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 2 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 11 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.15 Gbp per sample0130Gbp
Community composition
Roseburia 9.5%Faecalibacterium 8.9%Prevotella 8.5%Blautia_A 5.6%Phocaeicola 4.6%Bacteroides 4.1%Bifidobacterium 3.2%Ruminococcoides 2.7%Lachnospira 2.6%Fusicatenibacter 2.4%Gemmiger 1.9%Vescimonas 1.8%not assigned to a genus 5.6%other genera 38.6%

Genera, mean relative abundance over 13 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category15 100%
country15 100%15
health_condition15 100%15
subject_id15 100%15
collection_date15 100%15
detailed_location15 100%
health_condition_detail15 100%15
latitude15 100%15
location_locality15 100%15
location_region15 100%15
location_site15 100%15
longitude15 100%15
Papers (1)
  • Mode of Action of Psyllium in Reducing Gas Production from Inulin and its Interaction with Colonic Microbiota: A 24-hour, Randomized, Placebo-Controlled Trial in Healthy Human Volunteers. 2025 PMID 39732438 PMC11934246 own_data
Details
Archive description

Background: Recent studies show that colonic gas after ingestion of inulin can be reduced by co-administering psyllium.</p><p>Objective: We aimed to determine if slowing delivery of inulin to the colon by administering it in divided doses would mimic the effect of psyllium.</p><p>Methods: Healthy adults (n=17) were randomised to a single-blind, 3-arm, crossover trial. All consumed 20g inulin(I) powder dissolved in 500mL water and mixed with either 1) 20g psyllium husk (PI) or 2) 20g Maltodextrin (placebo) (MI) consumed as a single dose, or 3) 62.5ml divided doses of inulin(DI) given every 45 minutes over 6 hours. Breath Hydrogen (BH2) was measured over 24 hours, and stool microbiota was analysed using shotgun metagenomics.</p><p>Results: [mean(SD)] DI and PI significantly reduced area under the curve (AUC) BH2 0-360 mins compared to MI, p<0.001. AUC(0-6h) being (6199.4+/-2889.2) after DI and (6855+/-5137) after PI, significantly less than MI (9970.6 +/- 3102.7). This was associated with a significant increase in BH2 for both DI and PI during the evening from 360-720 (p=0.014) and overnight 720-1320 (p=0.002). Furthermore, there was an additional significant increase overnight in BH2 for DI compared to psyllium, DI=30423+/-15406, PI= 5671+/-4711 p<0.001. Those failing to show a fall in BH2 AUC0-6h with psyllium showed greater release of arabinose during in vitro fermentation. Metagenomic analysis identified two species abundantly expressed in non-responders, Clostridium spp. AM22_11AC and Phocaeicola dorei which are also correlated with BH2 production for PI treatment. Dietary FODMAP intake correlated inversely with BH2 AUC0-24h on psyllium and correlated with stool microbiome.</p><p>Conclusion: Divided administration of inulin mimics the effect of psyllium by reducing initial BH2 0-360 mins. BH2 is influenced by habitual dietary FODMAP intake, most likely due to associated changes in microbiome. Psyllium acts by both delaying transit to the colon and reducing colonic fermentation however degradation of psyllium by colonic microbiota may limit its effectiveness.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Metagenomic sequencing of stool samples from healthy”
  • body site study.description · “studies show that colonic gas after ingestion”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.title · “from healthy human volunteers from the EON”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN41277347collection_date2022-10-20R10.90biosample.attribute:collection_date2022-10-20
SAMN41277347countryGBR10.90sample.attr.geo_loc_nameUnited Kingdom: Nottingham
SAMN41277347health_conditionhealthy_controlR30.70paper.fulltext.methodsHealthy adults aged 18 y or older
SAMN41277347health_condition_detailHealthy adults free from gastrointestinal complaintsR30.70paper.fulltext.methodsHealthy adults aged 18 y or older
SAMN41277347latitude52.9540R10.90biosample.attribute:lat_lon52.9540 N 1.1550 W
SAMN41277347location_localityNottinghamR10.85biosample.attribute:geo_loc_nameUnited Kingdom: Nottingham
SAMN41277347location_regionEnglandR10.60biosample.attribute:lat_lon52.9540 N 1.1550 W
SAMN41277347location_siteNottingham Digestive Disease Centre, Queen's Medical Centre, NottinghamR30.70paper.fulltext.methodsNottingham Digestive Disease Centre, Queen's Medical Centre, Nottingham
SAMN41277347longitude-1.1550R10.90biosample.attribute:lat_lon52.9540 N 1.1550 W
SAMN41277347subject_idSAMN41277347R30.75design.one_sample_per_subject:fulltextasked to collect the samples beforehand and bring them on their first study day before
Sequencing

15 runs over 15 samples · mean 3.40 Gbp per run (median 4.15 Gbp, total 50.97 Gbp; 15 runs with a base count) · layout PAIRED 15 · platform ILLUMINA 15 · models Illumina NovaSeq 6000 (15) · 87% of runs with a Sandpiper profile · first public 2025-05-28

Authors (14)

Alhasani AT first · Modasia AA · Anodiyil M · Corsetti M · Aliyu AI · Crooks C · Marciani L · Reid J · Yakubov GE · Taylor M · Avery A · Harris H · Warren FJ · Spiller RC last

Downloads

PRJNA1109584.csv.gz (1.4 KB) · parquet (71.7 KB) — all 15 samples, every field with route and confidence · PRJNA1109584_determinations.csv.gz (1.9 KB) — 150 evidence rows

Samples (15 · every field this project has values for · hover a cell for its source)
Loading the sample table…